Form D · Biotechnology
AmpSport, Inc.
Decatur, GA · CIK 0001801202
Offering snapshot reported Oct 30, 2023 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2023 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Jan 12, 2022 | Initial | $550,000 | No comparison | 1 | SEC filing |
| Jan 27, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495951
Source: Form D, filed Oct 30, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Chiasson | Director |
| Harald B. Findlay | Director |
| Kenneth Merritt | Director |
| David Nichols | Director, Executive, Promoter |
| Oliver Sharpe | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1208 Conway Road
Decatur, GA, 30030
Decatur, GA, 30030